James Cavet BA, MBBS, FRCP, PhD

Dr Cavet trained in medical sciences at King's College, Cambridge, then studied clinical medicine, postgraduate medicine and haematology in Newcastle-upon-Tyne (including his PhD on Graft-versus-Host-Disease). Dr Cavet has been a Consultant Haematologist at The Christie since 2003 and is lead for myeloma, with interests in novel myeloma therapies, especially non-chemotherapy, AL amyloidosis, paraproteinaemic neuropathies, Castleman's disease treatment, stem cell transplantation and immunomodulation. He is a member of the MyelomaUK Early Phase Trial Network Steering Group.